Biotech

Latest Articles

Former Seagen chief executive officer reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2013 for a tre...

Ironwood produces further bid for $1B GI drug along with brand-new subgroup records

.On the heels of a phase 3 gain that stopped working to excite investors, Ironwood Pharmaceuticals i...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Don't cease Monte Rosa Therapies now. The Boston-based biotech is enjoying after authorizing a deal...

Jade takes exec staff with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also...

Septerna goes social along with upsized offering of $288M

.Commemorating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the open...

AbbVie makes Richter wealthier, paying for $25M to constitute breakthrough deal

.AbbVie has actually gone back to the source of its antipsychotic giant Vraylar trying to find anoth...

GenSight gets into last weeks of money runway as profits flow noses out of scope

.GenSight Biologics is actually weeks off of lacking cash. Once more. The biotech only has enough ca...

AZ licenses thrown away uncommon ailment drug to Monopar Rehabs

.Monopar Rehabs is recouping a drug from the scrap heap of AstraZeneca's unusual illness pipeline. I...

Arcus' new HIF-2a information in renal cancer cells mean possible advantage over Merck's Welireg, experts say

.With brand-new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of analyst...

Roche bets up to $1B to grow Dyno gene therapy shipping deal

.After creating a genetics treatment relationship with Dyno Rehabs in 2020, Roche is actually back f...

Lundbeck slashes worth of $250M Abide buyout after pain trouble

.Lundbeck is actually slashing the book worth of its own $250 thousand Abide Rehabs buyout in reacti...

Real- World Information Meets Scientific Test Layout: Optimizing Methods as well as Internet Site Choice

.The assimilation of real-world records (RWD) in to protocol feasibility as well as site option has ...

Where are they today? Overtaking past Ferocious 15 guest of honors

.At this year's Fierce Biotech Top in Boston, we overtook innovators in the biotech market who have ...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually setting down $30 million upfront to get Yale spinout Modifi Biosciences,...

Radiopharma Alpha-9 elevates $175M set C to fund clinical push

.Alpha-9 Oncology has elevated a $175 thousand series C round to stake its own clinical-stage radiop...

Ocuphire to change into gene treatment biotech through Opus acquistion

.Eye medicine manufacturer Ocuphire Pharma is actually obtaining gene therapy programmer Piece Genes...

Roche culls cough candidate, pivots KRAS program in Q3 update

.Roche's persistent cough program has faltered to a stop. The drugmaker, which axed the system after...

Merck- Gilead long-acting dental combo decreases HIV for 48 weeks

.Gilead Sciences and also Merck &amp Co. have actually directed their once-weekly HIV mix therapy pa...

Lykos approves FDA watch that MDMA authorization relies upon new trial

.Lykos Therapies may have lost three-quarters of its staff in the wake of the FDA's being rejected o...

Septerna prepares $158M IPO to fund readouts for GPCR pipe

.Septerna may be actually as yet to make known "any kind of significant scientific data," but the bi...